Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2006 12
2007 5
2008 6
2009 8
2010 9
2011 17
2012 13
2013 19
2014 14
2015 20
2016 20
2017 17
2018 12
2019 19
2020 23
2021 19
2022 18
2023 17
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

238 results

Results by year

Filters applied: . Clear all
Page 1
A quantitative weight-of-evidence method for confidence assessment of adverse outcome pathway networks: a case study on chemical-induced liver steatosis.
Verhoeven A, van Ertvelde J, Boeckmans J, Gatzios A, Jover R, Lindeman B, Lopez-Soop G, Rodrigues RM, Rapisarda A, Sanz-Serrano J, Stinckens M, Sepehri S, Teunis M, Vinken M, Jiang J, Vanhaecke T. Verhoeven A, et al. Among authors: vinken m. Toxicology. 2024 Apr 25:153814. doi: 10.1016/j.tox.2024.153814. Online ahead of print. Toxicology. 2024. PMID: 38677583
Novel clinical phenotypes, drug categorization, and outcome prediction in drug-induced cholestasis: Analysis of a database of 432 patients developed by literature review and machine learning support.
Moreno-Torres M, López-Pascual E, Rapisarda A, Quintás G, Drees A, Steffensen IL, Luechtefeld T, Serrano-Candelas E, de Lomana MG, Gadaleta D, Dirven H, Vinken M, Jover R. Moreno-Torres M, et al. Among authors: vinken m. Biomed Pharmacother. 2024 May;174:116530. doi: 10.1016/j.biopha.2024.116530. Epub 2024 Apr 3. Biomed Pharmacother. 2024. PMID: 38574623 Free article. Review.
Chemical-induced liver cancer: an adverse outcome pathway perspective.
Sanz-Serrano J, Callewaert E, De Boever S, Drees A, Verhoeven A, Vinken M. Sanz-Serrano J, et al. Among authors: vinken m. Expert Opin Drug Saf. 2024 Apr;23(4):425-438. doi: 10.1080/14740338.2024.2326479. Epub 2024 Mar 13. Expert Opin Drug Saf. 2024. PMID: 38430529 Review.
Protocol for designing INVITES-IN, a tool for assessing the internal validity of in vitro studies.
Svendsen C, Whaley P, Vist GE, Husøy T, Beronius A, Consiglio ED, Druwe I, Hartung T, Hatzi VI, Hoffmann S, Hooijmans CR, Machera K, Robinson JF, Roggen E, Rooney AA, Roth N, Spilioti E, Spyropoulou A, Tcheremenskaia O, Testai E, Vinken M, Mathisen GH. Svendsen C, et al. Among authors: vinken m. Evid Based Toxicol. 2023 Aug 31;1(1):1-15. doi: 10.1080/2833373x.2023.2232415. Evid Based Toxicol. 2023. PMID: 38264543 Free PMC article.
Report of the First ONTOX Stakeholder Network Meeting: Digging Under the Surface of ONTOX Together With the Stakeholders.
Diemar MG, Vinken M, Teunis M, Krul CAM, Busquet F, Zajac JD, Kandarova H, Corvi R, Rosso MZ, Kharina A, Bryndum LS, Santillo M, Bloch D, Kucheryavenko O, Panagiotakos D, Rogiers V, Beekhuijzen M, Giusti A, Najjar A, Courage C, Koenig T, Kolle S, Boonen H, Dhalluin S, Boberg J, Müller BP, Kukic P, Ritskes-Hoitinga M, Grasselli E, Zietek T, Stoddart G, Heusinkveld HJ, Castell JV, Benfenati E, Yang H, Perera S, Paini A, Kramer NI, Hartung T, Janssen M, Fritsche E, Jennen DGJ, Piumatti M, Rathman J, Marusczyk J, Milec L, Roggen EL. Diemar MG, et al. Among authors: vinken m. Altern Lab Anim. 2024 Mar;52(2):117-131. doi: 10.1177/02611929231225730. Epub 2024 Jan 18. Altern Lab Anim. 2024. PMID: 38235727 Free article.
238 results